Artifact GuideEU

EU MDR penalties and enforcement risk

The MDR does not publish one EU-wide fine table. Article 113 requires each Member State to set penalties for MDR infringements and to implement them.

This page helps separate national fine exposure from EU-level enforcement consequences such as inspections, corrective action, market restriction, withdrawal, recall, and certificate action.

Author
Sorena AI
Published
May 9, 2026
Updated
Jul 25, 2026
Sections
5

Structured answer sets in this page tree.

Primary sources
3

Cited legal and guidance references.

Publication metadata
Sorena AI
Published May 9, 2026
Updated Jul 25, 2026
Overview

EU MDR penalty work starts with Article 113, but enforcement risk is broader than fines. Member States set the penalty rules, while the MDR itself gives and notified bodies routes to request records, inspect operators, require corrective action, restrict devices, withdraw or recall products, and suspend, withdraw, or restrict certificates where requirements are no longer met.

Section 1

Penalty exposure starts with Member State rules

Article 113 is the MDR penalty provision: Member States must lay down penalty rules for infringements of the MDR, take the measures needed to implement them, and make the penalties effective, proportionate, and dissuasive. That is why a useful penalty assessment should not invent an EU-wide maximum fine.

For a device-specific issue, begin with a national-law mapping: the Member State, competent authority, economic-operator role, alleged MDR infringement, local penalty provision, and status of any authority contact. Article 113 does not decide whether a particular case attracts an administrative fine, criminal sanction, or another measure. That answer depends on the applicable Member State law and the facts. If the national rule is not supported by a current cited source, leave the amount and sanction type blank.

Check the national rule in force on the date of the alleged infringement and identify the procedural source separately from the penalty amount. National law may distinguish administrative and criminal proceedings, responsible legal and natural persons, limitation periods, aggravating factors, cooperation credit, and appeal routes. The MDR's Article 113 formula does not resolve any of those country-specific questions.

  • Record every relevant Member State: where the device was placed on the market, made available, put into service, investigated, or affected by the incident. A cross-border case may require more than one national-law assessment.
  • Name the operator role separately: manufacturer, authorised representative, importer, distributor, system or procedure pack producer, sponsor, or notified-body relationship.
  • Tie each penalty line to a specific MDR duty, such as technical documentation, QMS, clinical evaluation, PMS, vigilance reporting, UDI or registration, labelling, conformity assessment, or cooperation with .
  • Keep monetary fine amounts out of the artifact unless they come from a cited national source.
Section 2

EU-level obligations that can trigger enforcement

Penalty exposure normally follows a concrete MDR failure. The most enforcement-relevant records are the ones can request or inspect: technical documentation, EU declaration of conformity, certificates, QMS procedures, risk management, clinical evaluation, PMS records, vigilance reports, field safety corrective actions, and cooperation evidence.

Manufacturers must keep technical documentation, the EU declaration of conformity, and relevant certificates available for for at least 10 years after the last device covered by the declaration is placed on the market, or at least 15 years for implantable devices. A missing, incomplete, or incorrect response to an authority request can itself escalate risk because Article 10 allows authorities to restrict, withdraw, or recall a device until cooperation or complete and correct information is provided.

  • For manufacturers, preserve the Article 10 file: technical documentation, declaration of conformity, certificates and amendments, QMS procedures, risk management, PMS, vigilance, CAPA, and authority-response logs.
  • For importers, preserve checks that the device was CE marked, documentation existed, registration obligations were addressed, complaint/non-conforming-device registers were maintained, and manufacturer or authority escalation happened where required.
  • For distributors, preserve pre-market checks, complaint forwarding, storage and transport controls, and withdrawal or recall cooperation evidence.
  • For serious-risk scenarios, capture who informed and, where applicable, the notified body that issued the certificate.
Recommended next step

Build an MDR enforcement evidence file

Turn Article 113 penalty mapping, competent-authority measures, notified-body certificate status, recalls, withdrawals, and corrective actions into one authority-ready evidence record.

Section 3

Market restriction, withdrawal, recall, and corrective action

The MDR enforcement path depends on the risk and the type of non-compliance. Under Article 94, evaluate devices suspected of presenting an unacceptable risk or otherwise failing MDR requirements. If Article 95 applies, authorities can require corrective action proportionate to the risk, including market restrictions, specific requirements, withdrawal, or recall. A withdrawal addresses a device in the supply chain, while a recall seeks the return of a device already made available to the end user.

Article 97 covers other non-compliance where the device does not present an unacceptable health or safety risk. The operator still must end the non-compliance within a defined and communicated period; if it does not, the Member State can restrict or prohibit availability, or ensure recall or withdrawal. Article 98 separately supports preventive health protection measures where a potential risk justifies prohibition, restriction, special requirements, withdrawal, or recall.

  • Classify the enforcement route without treating it as a manufacturer election: Article 95 addresses devices presenting an unacceptable risk, Article 97 addresses other non-compliance, and Article 98 allows justified preventive health-protection measures.
  • Track the action required: bring into compliance, restrict availability, add specific requirements, withdraw, recall, confiscate, destroy, or render inoperable.
  • Keep the authority notice, inspection report, operator submissions, corrective-action plan, device traceability data, customer or user communications, and field safety notice history together.
  • When the device has an Article 56 certificate, include the notified body and the certificate identifier in the enforcement file.
Section 4

Notified body and certificate consequences

For devices requiring notified-body involvement, fines are not the only material consequence. Article 56 says certificates may be valid for a stated period not exceeding five years. If the notified body finds that MDR requirements are no longer met, it must, with regard to proportionality, suspend or withdraw the certificate or impose restrictions unless the manufacturer implements appropriate corrective action within the notified body's deadline.

Certificate evidence should identify the manufacturer, device or device group, risk classification, intended purpose where required, Basic UDI-DI where applicable, conformity assessment annex, tests and examinations, surveillance conditions, validity limits, and any supplement, restriction, suspension, reinstatement, withdrawal, refusal, or reissue history.

  • Check whether the device is covered by the certificate scope; Annex XII requires certificates to unambiguously identify covered devices.
  • Keep notified-body nonconformity findings, deadlines, corrective-action submissions, decisions, reasons, and certificate status changes.
  • Do not treat voluntary or unregulated certificates as a substitute for MDR conformity assessment by a properly designated notified body.
  • Use Commission/NANDO notified-body listings to verify designation and scope when the certificate or body status matters to enforcement risk.
Section 5

Practical evidence file for penalties and enforcement

An MDR penalties file should let counsel, regulatory, quality, and management reconstruct the exposure without relying on memory. It should show the MDR obligation at issue, each Member State penalty rule checked, the authority or notified body involved, what the operator did, and whether the device risk was eliminated, mitigated, restricted, withdrawn, recalled, or otherwise closed. Keep the legal assessment separate from the remediation log so that correcting the device issue is not mistaken for a decision that no penalty can follow.

For vigilance-linked matters, keep Article 87 serious-incident and field safety corrective action reports with the Article 89 investigation, risk assessment, field safety corrective action decision, authority communications, and field safety notice. For market-surveillance matters, keep the Article 93 inspection report, Article 94 evaluation basis, and any Article 95 to 98 measures or operator submissions.

  • Create one row per enforcement issue with device identifier, Basic UDI-DI where applicable, certificate number, operator role, Member State, MDR article, national penalty source, authority, notified body, owner, and status.
  • Attach retained documents: technical documentation, declarations, certificates, QMS procedures, risk files, clinical evaluation, PMS/PMCF outputs, complaint files, incident reports, FSCA records, field safety notices, and CAPA effectiveness checks.
  • Record all dates as evidence events, not guessed deadlines: authority request received, response sent, inspection completed, corrective action required, recall or withdrawal started, certificate action taken, and closure accepted.
  • Escalate to counsel qualified in the relevant Member State when the fact pattern needs a monetary fine range, criminal-law assessment, limitation-period analysis, personal-liability analysis, reimbursement impact, or country-specific appeal route.
Primary sources

References and citations

eur-lex.europa.eu
Referenced sections
  • Articles 87, 89, 93, 99, and 100 ground vigilance reports, serious-incident investigations, inspection reports, operator submissions, and market-surveillance information flows.
Related guides

Explore more topics

Custom-made medical devices under the EU MDR | EU MDR FAQ
Concise EU MDR FAQ on custom-made device definition, mass-produced exclusions, Annex XIII statements, documentation, conformity assessment, PMS, vigilance, and records to retain.
EU MDR Annex II and III Technical Documentation
Build an MDR technical documentation index for Annex II device files and Annex III post-market surveillance evidence, including GSPR, risk, clinical, PMS, UDI, and EUDAMED records.
EU MDR Annex VIII Classification Guide
Classify EU MDR medical devices under Annex VIII using intended purpose, duration, invasiveness, active device and software rules, and conformity assessment impact.
EU MDR Annex XVI products without a medical purpose
EU MDR guide for Annex XVI products: listed groups, common specifications, binding reclassification rules, clinical evidence, notified-body route, transition conditions, UDI, EUDAMED, PMS, and vigilance.
EU MDR Applicability Test
Test whether a product, accessory, software function, or Annex XVI product falls under the EU Medical Device Regulation, and record the evidence for the next classification step.
EU MDR change assessment workflow
Assess EU MDR device, design, software, intended purpose, QMS, clinical, PMS, UDI, classification, and notified-body impacts before releasing a medical device change.
EU MDR Checklist for Medical Device Compliance
Practical EU MDR checklist covering qualification, classification, conformity assessment, technical documentation, GSPR, clinical evidence, UDI, EUDAMED, PMS, vigilance, QMS, and legacy transition evidence.
EU MDR classification workflow
A concrete EU MDR classification workflow for intended purpose, device or accessory qualification, Annex VIII rule selection, Rule 11 software review, class outcome, and notified body impact.
EU MDR Clinical Evaluation Overview
EU MDR clinical evaluation overview covering Article 61, Annex XIV, clinical data sources, equivalence, PMCF, CER evidence, notified body review, GSPR, and benefit-risk support.
EU MDR Clinical Evaluation Report Template
A cited EU MDR clinical evaluation report template covering intended purpose, GSPR linkage, clinical data appraisal, equivalence limits, PMCF, conclusions, and reviewer signoff.
EU MDR clinical evidence guide
EU MDR guide to clinical evaluation, clinical investigations, equivalence, PMCF, GSPR support, technical documentation, and notified-body review.
EU MDR compliance obligations
EU MDR compliance guide for device qualification, classification, conformity assessment, QMS, technical documentation, UDI, EUDAMED, PMS, vigilance, and legacy transition controls.
EU MDR conformity route workflow
EU MDR workflow for classifying a device, choosing the conformity assessment route, preparing technical and QMS evidence, and reaching certificate, DoC, UDI, EUDAMED, and CE outputs.
EU MDR deadlines and compliance calendar
EU MDR calendar for application, conditional legacy-device transition, UDI carrier dates, mandatory EUDAMED modules, and recurring compliance reviews.
EU MDR Device Classification Guide
Classify an EU MDR medical device by intended purpose, Annex VIII duration, invasiveness, active-device and software rules, then document the conformity route impact.
EU MDR EUDAMED and UDI registration
cited MDR guide to Basic UDI-DI, UDI-DI, EUDAMED device registration, actor roles, labels, technical documentation, and UDI data governance.
EU MDR FAQ: qualification, evidence, UDI, and transition
Concise EU MDR FAQ covering device qualification, software classification, accessories, custom-made devices, clinical evidence, UDI, EUDAMED, notified bodies, significant changes, and legacy transition.
EU MDR Legacy Device Transition
EU MDR legacy-device guide to Article 120 eligibility, class-based end dates, certificate validity, significant changes, surveillance, and evidence.
EU MDR notified body route selection
Choose an EU MDR conformity assessment route by device class, Article 52 option, notified body designation scope, QMS readiness, technical documentation, clinical evidence, and certificate evidence.
EU MDR PMS and Vigilance Guide
EU MDR guide to post-market surveillance, PMCF updates, PMS reports, PSURs, serious incident reporting, FSCA/FSN handling, trend reporting, and evidence records.
EU MDR PMS and vigilance records
Cited EU MDR guide to PMS plans, PMS reports, PSURs, PMCF updates, serious incident and FSCA reporting, trend reporting, and EUDAMED evidence handling.
EU MDR PMS Plan Template for Medical Devices
A cited EU MDR post-market surveillance plan template covering device scope, PMS data sources, PMCF linkage, vigilance, trend reporting, PMSR or PSUR outputs, roles, cadence, and evidence records.
EU MDR QMS and technical file evidence map
Map EU MDR Article 10 QMS duties to Annex II and Annex III technical documentation, PMS, vigilance, UDI records, and notified-body review evidence.
EU MDR QMS requirements under Article 10
EU MDR QMS guide for Article 10 manufacturer controls covering regulatory strategy, design, risk, clinical evaluation, PMS, vigilance, UDI, suppliers, CAPA, and conformity records.
EU MDR qualification and borderline products
EU MDR qualification guide for medical purpose claims, accessories, software, Annex XVI products, and borderline routes to classification and conformity assessment.
EU MDR qualification workflow
A concrete EU MDR workflow for deciding whether a product is a medical device, accessory, Annex XVI product, IVD interface, medicinal-product interface, or non-MDR product before classification and conformity assessment.
EU MDR requirements checklist
Concrete EU MDR requirements for medical-device scope, classification, GSPR, conformity assessment, technical documentation, QMS, clinical evidence, UDI, EUDAMED, PMS, vigilance, and economic-operator records.
EU MDR Rule 11 software classification
Classify MDR medical device software under Rule 11 using intended purpose, diagnosis or therapy decision impact, physiological monitoring, conformity route, clinical evidence, and software-change records.
EU MDR significant changes FAQ: legacy-device transition and notified-body review
FAQ on MDR significant changes for legacy devices, including intended-purpose, design, software, material, sterilisation, clinical, QMS, notified-body, and evidence impacts.
EU MDR SSCP: Devices and Requirements
Decide whether an EU medical device needs an SSCP, see worked class IIa, IIb, and III examples, and check the required content, evidence, publication, and update controls.
EU MDR transition timeline and end dates
EU MDR chronology for 2021 application, 2023 amendments, 2024 eligibility milestones, and conditional 2026, 2027, and 2028 transition endpoints.
EU MDR UDI and EUDAMED registration guide
EU MDR guide to Basic UDI-DI, UDI-DI, UDI carriers, EUDAMED actor and device registration, change impacts, and evidence governance.
EU MDR vigilance reporting workflow
Concrete EU MDR vigilance workflow for incident intake, serious incident assessment, FSCA and FSN handling, trend reporting, EUDAMED caveats, CAPA, PMS, clinical evaluation updates, and records.
How should Basic UDI-DI and UDI-DI be assigned under the EU MDR? | EU MDR FAQ
EU MDR FAQ on Basic UDI-DI grouping, device and package UDI-DIs, UDI carriers, EUDAMED registration, change triggers, and required records.
MDR vs AI Act for medical-device software
Compare MDR and AI Act scope, high-risk classification, conformity assessment, evidence, monitoring, and timing for AI-enabled medical devices.
MDR vs EU Product Liability Directive
Compare MDR compliance evidence with EU product-liability claims, responsible parties, disclosure, presumptions, damage, and the December 2026 transition.
MDR vs GPSR: medical-device boundary checks
Compare MDR medical-device scope with general product-safety fallback questions for borderline, non-medical, and Annex XVI products.
MDR vs IVDR: medical devices and IVDs compared
Compare EU MDR and IVDR scope, classification, conformity routes, technical documentation, clinical or performance evidence, UDI, EUDAMED, PMS, and vigilance.
What should an EU MDR PMCF plan and report cover? | EU MDR FAQ
Under the EU MDR, PMCF is part of PMS and clinical evaluation. See what the plan, activities, report, updates, and retained evidence should cover.
What should manufacturers do when an EU MDR classification changes? | EU MDR FAQ
Concise EU MDR FAQ on classification changes, intended purpose, software, notified-body route impact, certificates, technical documentation, and retained evidence.
When can clinical equivalence be used under the EU MDR?
EU MDR FAQ on clinical equivalence, including technical, biological, and clinical characteristics, access to equivalent-device data, class III and implantable-device limits, clinical evaluation, PMCF, and retained evidence.
When do software or products make medical purpose claims under the EU MDR? | EU MDR FAQ
EU MDR FAQ on medical purpose claims, intended purpose evidence, software qualification, Annex XVI contrasts, and records to keep.
When is a PSUR required under the EU MDR and what should it contain? | EU MDR FAQ
EU MDR FAQ on PSUR scope, content, update cadence, PMS and PMCF links, notified-body handling, EUDAMED submission, and evidence to retain.
When is an accessory regulated under the EU MDR? | EU MDR FAQ
EU MDR FAQ on when an article is a medical device accessory, how intended purpose affects classification, and what evidence to keep.
When is software a medical device under the EU MDR?
EU MDR FAQ on medical device software qualification, Rule 11 and other classification rules, modules, evidence, software changes, UDI, and EUDAMED.
Which EUDAMED modules matter under the EU MDR? | EU MDR FAQ
EU MDR FAQ mapping EUDAMED modules to actor registration, UDI/device data, certificates, clinical investigations, vigilance/PMS, market surveillance, and practical records.